SENSITIVITY OF PET MEASUREMENTS WITH C-11 RACLOPRIDE TO CHANGES IN ENDOGENOUS DOPAMINE

被引:0
|
作者
VOLKOW, ND
FOWLER, JS
WANG, GJ
SCHLYER, D
LOGAN, J
DEWEY, SL
HITZEMANN, R
ANGRIST, B
LIEBERMANN, J
MACGREGOR, RR
WOLF, AP
机构
[1] BROOKHAVEN NATL LAB,DEPT MED,UPTON,NY 11973
[2] BROOKHAVEN NATL LAB,DEPT CHEM,UPTON,NY 11973
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:P67 / P67
页数:1
相关论文
共 50 条
  • [21] Within-subject comparison of the sensitivity of [11C]-(+)-PHNO and [11C]raclopride to amphetamine induced changes in endogenous dopamine in healthy human volunteers
    Shotbolt, Paul
    Tziortzi, Andri
    Miller, Sam
    Searle, Graham
    Van der Aart, Jasper
    Abanades, Sergio
    Plisson, Christophe
    Huiban, Mickael
    Searle, Graham
    Beaver, John
    Gunn, Roger
    Laruelle, Marc
    Rabiner, Eugenii A.
    NEUROIMAGE, 2010, 52 : S42 - S43
  • [22] USP STANDARDS FOR RACLOPRIDE C-11 INJECTION
    MOERLEIN, SM
    PERLMUTTER, JS
    WELCH, MJ
    PHARMACOPEIAL FORUM, 1995, 21 (01): : 172 - 176
  • [23] STRIATAL DOPAMINE-D2 RECEPTORS IN PATIENTS WITH NARCOLEPSY MEASURED WITH POSITRON EMISSION TOMOGRAPHY (PET) AND C-11 RACLOPRIDE
    PARKES, D
    WEINDL, A
    MEIEREWERT, K
    DAHLITZ, M
    ANTONINI, A
    KHAN, N
    BEER, HF
    LEENDERS, KL
    NEUROLOGY, 1993, 43 (04) : A337 - A337
  • [24] THE SEROTONIN-DOPAMINE INTERACTION MEASURED WITH POSITRON EMISSION TOMOGRAPHY (PET) AND C-11 RACLOPRIDE IN NORMAL HUMAN-SUBJECTS
    SMITH, GS
    DEWEY, SL
    LOGAN, J
    BRODIE, JD
    VITKUN, S
    SIMKOWITZ, P
    ALEXOFF, D
    FOWLER, JS
    VOLKOW, ND
    WOLF, AP
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P85 - P85
  • [25] A PET study on the acute effect of ethanol on striatal D2 dopamine receptors with [C-11]raclopride in healthy males
    Salonen, I
    Hietala, J
    Laihinen, A
    Lehikoinen, P
    Leino, L
    Nagren, K
    Ruotsalainen, U
    Oikonen, V
    Tuokkola, T
    Nanto, V
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1997, 12 (02) : 145 - 152
  • [26] Biodistribution and dosimetry estimates of [C-11]raclopride.
    Mathis, CA
    Simpson, NR
    Blastos, BP
    Shedwick, LA
    Smith, GS
    Swanson, DP
    Mintun, MA
    Stabin, M
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1041 - 1041
  • [27] Biodistribution and radiation dose estimates for [C-11]raclopride
    Herscovitch, P
    Schmall, B
    Doudet, DJ
    Carson, RE
    Eckelman, WC
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 951 - 951
  • [28] QUANTITATIVE PET-SCAN STUDIES ON HUMAN DOPAMINE-D2 RECEPTORS USING C-11 RACLOPRIDE, A SUBSTITUTED BENZAMIDE
    FARDE, L
    EHRIN, E
    HALL, H
    SEDVALL, G
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1986, 31 (1-4) : 4 - 4
  • [29] Quantification of amphetamine-induced changes in [C-11]raclopride binding with continuous infusion
    Carson, RE
    Breier, A
    deBartolomeis, A
    Saunders, RC
    Su, TP
    Schmall, B
    Der, MG
    Pickar, D
    Eckelman, WC
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (04): : 437 - 447
  • [30] THE EFFECT OF CHANGES IN BLOOD-FLOW ON THE DISTRIBUTION VOLUME OF [C-11] RACLOPRIDE BINDING
    LOGAN, J
    VOLKOW, ND
    FOWLER, JS
    WANG, GJ
    DEWEY, SL
    SCHLYER, DJ
    MACGREGOR, RR
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P200 - P200